Genscript Biotech Corporation
GNNSF | OTC
$4.50
$0.00 (0.00%)
At close: Oct 28, 2026, 9:30 AM ET
$4.50
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 5:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 217.36M | 173.59M | 293.21M | 131.99M | 399.3M | 1.45B | 1.4B | 1.02B | 782.25M | 1.18B | 957.62M |
Short-Term Investments | 613.82M | 669.41M | 103.99M | 489.2M | 1.47B | 481.65M | 499.88M | 228.89M | 458.33M | 222.53M | 243.24M |
Long-Term Investments | 2.99B | 3.11B | 3.61B | 3.79B | 96.73M | -396.24M | 35.87M | 16.03M | 18.72M | 18.47M | 14.56M |
Other Long-Term Assets | 38.4M | 26.53M | 36.89M | 43.54M | 189.67M | 642.98M | -16.46M | -15.05M | -6.34M | -5.09M | -3.09M |
Receivables | 156.78M | 133.92M | 132.18M | 118.72M | 130.81M | 218.83M | 132.51M | 104.28M | 102.34M | 142.44M | 92.64M |
Inventory | 45.24M | 39.59M | 38.8M | 31.1M | 50.86M | 53.35M | 51.52M | 59.94M | 49.9M | 44.36M | 34.89M |
Other Current Assets | 45.85M | 40.36M | 67.47M | 54.68M | 147.14M | 150.89M | 138.58M | 134.89M | 89.91M | 41.07M | 41.32M |
Total Current Assets | 1.08B | 1.06B | 1.18B | 834.98M | 2.21B | 2.35B | 2.47B | 1.76B | 1.5B | 1.64B | 1.37B |
Property-Plant & Equipment | 650.77M | 623.19M | 597.88M | 595.62M | 813.72M | 750.95M | 686.45M | 624.67M | 548.73M | 486.91M | 436.99M |
Goodwill & Intangibles | 14.79M | 14.62M | 14.11M | 14.37M | 17.43M | 20M | 25.12M | 26.36M | 39.54M | 40.57M | 41.39M |
Total Long-Term Assets | 3.71B | 3.8B | 4.26B | 4.44B | 1.12B | 1.03B | 747.43M | 667.06M | 606.99M | 545.95M | 492.95M |
Total Assets | 4.79B | 4.85B | 5.43B | 5.28B | 3.33B | 3.39B | 3.38B | 2.55B | 2.14B | 2.23B | 1.89B |
Account Payables | 41.06M | 36.78M | 51.73M | 29.84M | 59.21M | 39.96M | 40.33M | 55.76M | 32.87M | 30.18M | 27.24M |
Deferred Revenue | 64.42M | 48.19M | n/a | n/a | n/a | n/a | -44.66M | -44.79M | -14.09M | -8.03M | -25.29M |
Short-Term Debt | 203.19M | 468.15M | 155.46M | 88.75M | 31.02M | 57.01M | 35.21M | 33.68M | 6.7M | 521K | 20.55M |
Other Current Liabilities | 361.31M | 74.11M | 319.34M | 111.38M | 239.62M | 224.2M | 167.34M | 235.41M | 332.05M | 218.99M | 224.38M |
Total Current Liabilities | 726.75M | 720.08M | 600.53M | 307.34M | 533M | 494.81M | 437.9M | 545.98M | 512.83M | 413.31M | 421.29M |
Long-Term Debt | 90.06M | 85.92M | 329.89M | 570.48M | 846.15M | 287.21M | 270.61M | 261.01M | 189.51M | 121.07M | 18.21M |
Other Long-Term Liabilities | 1.29M | 1.3M | 28.07M | 20.1M | 30.92M | 443.44M | 434.98M | 236.02M | -9.44M | 233.44M | -12.3M |
Total Long-Term Liabilities | 154.87M | 156.22M | 412.77M | 647.57M | 974.66M | 848.14M | 771.21M | 567.23M | 461.43M | 381.86M | 18.21M |
Total Liabilities | 881.62M | 876.3M | 1.01B | 954.91M | 1.51B | 1.34B | 1.3B | 1.18B | 1.26B | 846.18M | 728.71M |
Total Debt | 254.68M | 258.84M | 548.52M | 723.74M | 989.23M | 416.99M | 380.89M | 349.8M | 229.23M | 156.45M | 55.8M |
Book Value | 3.91B | 3.98B | 4.42B | 4.32B | 1.82B | 2.04B | 2.09B | 1.36B | 888.36M | 1.39B | 1.16B |
Book Value Per Share | 1.79 | 1.78 | 2.05 | 1.98 | 0.86 | 0.97 | 0.99 | 0.65 | 0.42 | 0.67 | 0.59 |
Common Stock | 2.19M | 2.18M | 2.18M | 2.14M | 2.13M | 2.12M | 2.12M | 2.11M | 2.11M | 2.1M | 2.08M |
Retained Earnings | 1.67B | 1.8B | 2.32B | 2.36B | -772.84M | -611.52M | -595.83M | -502.25M | -654.07M | -275.4M | -266.13M |
Comprehensive Income | 233.92M | 176.79M | 4.42B | -20.56M | 19.28M | 714.82M | 34.12M | 49.57M | 64.43M | 60.78M | 35.87M |
Shareholders Equity | 3.88B | 3.96B | 4.42B | 4.32B | 1.21B | 1.39B | 1.35B | 1.01B | 757.35M | 1.05B | 1.01B |
Total Investments | 3.6B | 3.78B | 3.71B | 4.28B | 1.57B | 85.41M | 535.76M | 244.92M | 477.05M | 241M | 257.8M |
Add to Watchlist
Select watchlists to add or remove GNNSF